Historically, animal numbers have most often been in the hundreds for experiments designed to estimate the dose reduction factor (DRF) of a radiation countermeasure treatment compared to a control treatment. Before 2010, researchers had to rely on previous experience, both from others and their own, to determine the number of animals needed for a DRF experiment. In 2010, a formal sample size formula was developed by Kodell et al. This theoretical work showed that sample sizes for realistic, yet hypothetical, DRF experiments could be less than a hundred animals and still have sufficient power to detect clinically meaningful DRF values. However, researchers have been slow to use the formula for their DRF experiments, whether from ignorance to its existence or hesitancy to depart from "tried and true" sample sizes. Here, we adapt the sample size formula to better fit usual DRF experiments, and, importantly, we provide real experimental evidence from two independent DRF experiments that sample sizes smaller than what have typically been used can still statistically detect clinically meaningful DRF values. In addition, we update a literature review of DRF experiments which can be used to inform future DRF experiments, provide answers to questions that researchers have asked when considering sample size calculations rather than solely relying on previous experience, whether their own or others', and, in the supplementary material, provide R code implementing the formula, along with several exercises to familiarize the user with the adapted formula.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513753PMC
http://dx.doi.org/10.1667/RADE-22-00124.1DOI Listing

Publication Analysis

Top Keywords

drf experiments
24
sample size
16
sample sizes
12
drf
10
animal numbers
8
radiation countermeasure
8
experiments
8
size calculations
8
previous experience
8
size formula
8

Similar Publications

An examination of the dose rate effect in mice assuming that the carcinogenic effect of radiation is life shortening resulting from a tissue reaction.

Int J Radiat Biol

January 2025

Department of Radiation Biosciences, Radiation Effects Research Foundation, Hiroshima, Japan.

Purpose: Radiation exposures do not seem to increase the proportion of mice dying from tumors, but rather cause a shift in the appearance of spontaneous cancers, allowing them to appear earlier, and hence produce a life shortening effect. Then, it was possible to estimate the effect of the dose rate on the carcinogenic effects of radiation using life shortening effects as a measure.

Conclusion: The dose response for the induction of life shortening was linear under acute exposure conditions, which indicates that the response under chronic exposure conditions is also likely to be linear, and hence the dose rate factor (DRF) would be constant throughout the dose.

View Article and Find Full Text PDF

The development of innovative strategies enabling chemical reactions in living systems is of great interest for exploring and manipulating biological processes. Herein, we present a pioneering approach based on both bioorthogonal and confined chemistry for intracellular drug synthesis. Exploiting a click-to-release reaction, we engineered nanoparticles capable of synthesizing drugs within cellular environments through bioorthogonal reactions with cyclooctynes.

View Article and Find Full Text PDF

Motor imagery is accompanied by a subjective multisensory experience. This sensory experience is thought to result from the deployment of internal models developed for the execution and monitoring of overt actions. If so, how is it that motor imagery does not lead to overt execution? It has been proposed that inhibitory mechanisms may prevent execution during imagined actions such as imagined typing.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the mechanical principles of external fixation and resistance training for wrist rehabilitation after a distal radius fracture (DRF).
  • It proposes two wearable exoskeleton devices: an adjustable fixation device (AFD) for early-stage protection and mobilization, and a resistance training device (RTD) for later-stage muscle recovery.
  • Experimental tests indicate that the AFD effectively monitors joint angles and the RTD enhances muscle strength, supporting active rehabilitation for DRF patients.
View Article and Find Full Text PDF

The clinical management of severe COVID-19 cases is not yet well resolved. Therefore, it is important to identify and characterize cell signaling pathways involved in virus pathogenesis that can be targeted therapeutically. Envelope (E) protein is a structural protein of the virus, which is known to be highly expressed in the infected host cell and is a key virulence factor; however, its role is poorly characterized.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!